It is a healthcare private limited company based in Mumbai, Maharashtra, India, established in 2017.
2017 | Mumbai, Maharashtra, India | ActiveCypress Pharmaceuticals Private Limited, a active private limited company, was established on 07 March 2017 in Mumbai, Maharashtra, India. Engaging in ayurvedic products & services within the trade sector, it holds CIN: U74999MH2017PTC292146. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹1.38 Cr and a paid-up capital of ₹1.30 Cr.
It upholds a compliant status. Its leadership includes Lav Kumar (Director), Rakesh Kumar Ranjan (Director). Past directors included Sharad Tiwari, Onkar Nath Prasad, Lav Kumar. Its latest AGM occurred on 31 December 2020, with the balance sheet filed on 31 March 2020. It is based at Flat No. F/604, Elite Building Kalyan Shil Road, Nilje, Mumbai, Maharashtra, 421203.
U74999MH2017PTC292146
292146
07 March 2017
₹1.38 Cr
₹1.30 Cr
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Cypress Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Lav Kumar | Director | 20 Jul 2020 | Current |
| Rakesh Kumar Ranjan | Director | 26 Aug 2019 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 20 Jan 2018 | Past |
| Pramod Abcsdd | Director | 20 Jul 2020 | Past |
| Pramod Abcsdd | Director | 05 Sep 2022 | Past |
| Pramod Abcsdd | Director | 22 Apr 2019 | Past |
| Pramod Abcsdd | Director | 26 Aug 2019 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Cypress Pharmaceuticals Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 83.81% decrease. The company also saw a substantial fall in profitability, with a 19.95% decrease in profit. The company's net worth observed a substantial decline by a decrease of 118.92%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2020, Cypress Pharmaceuticals had a promoter holding of 7.52% and a public holding of 92.48%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Cypress Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Cypress Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cypress Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Cypress Pharmaceuticals Private Limited last Annual general meeting of members was held on 31 Dec 2020 as per latest MCA records. was recorded as a recent event.
Progress on Lav Kumar was appointed as a Director was appointed as a Director on 20 Jul 2020 & has been associated with this company since 5 years 4 months . was documented.
Cypress Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2020 with Roc Mumbai. was recorded as a recent event.
The activity Rakesh Kumar Ranjan was appointed as a Director was appointed as a Director on 26 Aug 2019 & has been associated with this company since 6 years 3 months . was completed.
The activity Cypress Pharmaceuticals Private Limited was registered on 07 Mar 2017 with Roc Mumbai & aged 8 years 8 months as per MCA records. was completed.
The CIN of Cypress Pharmaceuticals Private Limited is U74999MH2017PTC292146.
Cypress Pharmaceuticals Private Limited is headquartered at Flat No. F/604, Elite Building Kalyan Shil Road, Nilje, Mumbai, Maharashtra, 421203.
Cypress Pharmaceuticals Private Limited was incorporated on 07 March 2017.
The current directors of Cypress Pharmaceuticals Private Limited are
The primary industry of Cypress Pharmaceuticals Private Limited is Trade.
Cypress Pharmaceuticals Private Limited is unlisted.
The authorized capital of Cypress Pharmaceuticals Private Limited is ₹1.38 Cr, and the paid-up capital is ₹1.30 Cr.
The compliance status of Cypress Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX